Skip to main content
Log in

Cancer Immunology, Immunotherapy

Publishing model:
Open access

Overview

Cancer Immunology, Immunotherapy is providing a timely and open access publication of original discovery and developments in basic and translational research in the field of cancer immunology and immunotherapy.

Editor-in-Chief
  • Haidong Dong
Journal Impact Factor
4.6 (2023)
5-year Journal Impact Factor
5.4 (2023)
Submission to first decision (median)
3 days
Downloads
1,507,571 (2024)

Calls for papers

View all calls for papers

Latest articles

Journal updates

Journal information

Electronic ISSN
1432-0851
Print ISSN
0340-7004
Abstracted and indexed in
  1. AGRICOLA
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. Biological Abstracts
  6. CLOCKSS
  7. CNKI
  8. CNPIEC
  9. Chemical Abstracts Service (CAS)
  10. Current Contents/Life Sciences
  11. DOAJ
  12. Dimensions
  13. EBSCO
  14. EMBASE
  15. Google Scholar
  16. Japanese Science and Technology Agency (JST)
  17. Medline
  18. Naver
  19. Norwegian Register for Scientific Journals and Series
  20. OCLC WorldCat Discovery Service
  21. Pathway Studio
  22. Portico
  23. ProQuest
  24. PubMedCentral
  25. Reaxys
  26. SCImago
  27. SCOPUS
  28. Science Citation Index Expanded (SCIE)
  29. Semantic Scholar
  30. TD Net Discovery Service
  31. UGC-CARE List (India)
  32. Wanfang
Copyright information

Rights and permissions

Editorial policies

© Springer-Verlag GmbH Germany, part of Springer Nature

Journal navigation